BF Biosciences Ltd
KAR:BFBIOHealth TechnologyPSX:ALLSHRPSX:KMIALLSHRRs 126.93+0.68%LiveIn session · ≈ AED 1.68 · Market cap $41.34M · Next earnings Wed 2 Dec
| PKR millions | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM | Trend | YoY |
|---|---|---|---|---|---|---|---|---|
| Depreciation & amortization | 23.4 | 28.3 | 34.3 | 36.1 | 193.6 | 270.7 | +39.8% | |
| Change in working capital | (76.9) | (83.3) | (422.4) | (78.5) | (394.3) | (804.8) | −104.1% | |
| Operating cash flow | 583.7 | 292.0 | (232.9) | 519.5 | 282.6 | 306.1 | +8.3% | |
| Capital expenditure | (941.1) | (1,130.2) | (1,970.0) | (143.1) | (329.5) | (513.9) | −56.0% | |
| Dividends paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Free cash flow | (357.4) | (838.1) | (2,201.3) | 376.4 | (46.9) | (207.9) | −342.8% |
PKR millionsUpdated 30 Sep 2025 ·
ⓘ
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
TTM ends 2026-03-31 and uses four consecutive reported quarters.
